RecallRadar

FDA Drug recall D-0820-2026

Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic,…

On 2026-09-09 the FDA classified a Class II recall of Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic,… by Baxter Healthcare, citing CGMP Deviations.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0820-2026
ClassificationClass II
Statusongoing
Initiated2026-08-06
Published2026-09-09
Last updated2026-09-15 05:30 UTC
CompanyBaxter Healthcare
DistributionUS

Product

Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.

Reason

CGMP Deviations

Identifiers

ndc0338-3552-48
ndc0338-3551-48
ndc0338-3580-48
ndc0338-3581-01
ndc0338-3582-01
ndc0338-3583-01
ndc0338-0122-04
ndc0338-0124-04
code_infoLot # NC193894, Exp Date: 04/25/2027.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-15 05:30 UTC. Current status: ongoing.

Other recalls by Baxter Healthcare

All Baxter Healthcare recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0820-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.